Cytek Biosciences Q2 Revenue USD 48.14 Million
CTKB•Full-year outlook
Cytek Biosciences expects FY revenue of $207 million to $212 million, compared with the IBES estimate of $208.8 million.
Q2 financial results
Aug 05 (Reuters) - Cytek Biosciences Q2 revenue was $48.14 million.
- Q2 adjusted gross margin: 59%
- Q2 adjusted EBITDA: $(1.541) million
- Q2 pretax profit: $(11.643) million
- Q2 net income: $(12.158) million
